Search

Search Constraints

You searched for: Author/Creator Storto, Alexandre

Search Results

1. Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients. (17th September 2021)

2. High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients. (24th April 2015)

3. High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients. (24th April 2015)

4. Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response. (8th March 2015)

6. Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. (3rd February 2018)

7. Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. (June 2021)

8. Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. (24th January 2020)

9. Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients. (20th May 2021)

10. Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. Issue 8 (August 2022)